The FDA has approved four different Covid-19 vaccine products as booster doses.
The FDA has authorized a modified emergency use authorization for four Covid-19 vaccines that can be used as booster shots and additional doses.
FDA Director-General Eric Domingo said AstraZeneca, Pfizer, and Sinovac could be used as homologous vaccinations or the same type of vaccine as a third injection in a filmed public address that aired Tuesday.
“Ibig sabihin, kapag naka-dalawang Pfizer, maaring magbigay ng isa pa (This means, if you’ve already had two Pfizer shots, you can have another one after six months,” he explained.
Meanwhile, regardless of the vaccine brand of the first two doses or primary series, the single-dose Sputnik Light could be used as a booster injection or additional dosage.
The Department of Health (DOH), according to Domingo, has authorized vaccination brands to be mixed and matched.
The Department of Health said Monday night that fully immunized healthcare professionals can begin receiving their third dosage or booster shot of the Covid-19 vaccine on November 17.
Regardless of which brand was used in the initial series, the DOH suggested Moderna, Pfizer, and Sinovac as booster doses.
The National Vaccine Operations Center has yet to issue instructions on how booster injections should be administered.